首页 > 最新文献

International journal of physiology, pathophysiology and pharmacology最新文献

英文 中文
The protective effect of melatonin on chronic paradoxical sleep deprivation induced metabolic and memory deficit in rats. 褪黑素对慢性睡眠剥夺引起的大鼠代谢和记忆缺陷的保护作用。
Omyma G Ahmed, Ghada S Mahmoud, Selvia S Samy, Sally A Sayed

Backgrounds: Impaired sleep is independent risk factor of neurodegeneration and dementia. Chronic insomnia impairs melatonin (MEL) production that is directly proportionate to its duration. The underlying mechanisms linking sleep loss to dementia and the possible therapeutic effect of melatonin have not been fully elucidated. Previous research showed great controversy concerning the effects of paradoxical sleep deprivation (PSD) on body weight, serum lipoproteins, and inflammatory cytokines.

Goals: To examine the effect of chronic paradoxical sleep deprivation (PSD) with and without MEL supplementation on memory using RAWM, parameters of metabolic syndrome (MS), liver enzymes, serum cortisol, and inflammatory cytokines as well as liver, colon, and brain histopathology.

Methods: Forty rats were divided into four groups ten animals each; C: control, G: grid group, SD: sleep deprivation group, and SD+MEL sleep deprivation treated with melatonin.

Results: MEL supplementation reversed PSD-induced memory deficits (P<0.05), the elevation of serum cortisol (P<0.001), glucose (P<0.05), ALT (P<0.05), AST (P<0.001), TNF-alpha (P<0.001), IL-10 (P<0.01) and improved colon, liver, and brain architecture. Melatonin reduced body weight (P<0.05), total cholesterol, LDL-c, and triglycerides as well as increased HDL-c (P<0.001).

Conclusion: MEL has a protective effect against chronic PSD-induced metabolic malfunction and cognitive deterioration by reducing stress, improving immunity, and maintaining colonic wall integrity.

背景:睡眠障碍是神经变性和痴呆的独立危险因素。慢性失眠损害褪黑素(MEL)的产生,这与持续时间成正比。睡眠不足与痴呆之间的潜在机制以及褪黑激素可能的治疗效果尚未完全阐明。矛盾睡眠剥夺(PSD)对体重、血清脂蛋白和炎症因子的影响在以往的研究中存在很大的争议。目的:通过RAWM、代谢综合征(MS)参数、肝酶、血清皮质醇、炎性细胞因子以及肝脏、结肠和脑组织病理学检查慢性睡眠剥夺(PSD)伴和不伴MEL补充对记忆的影响。方法:40只大鼠分为4组,每组10只;C:对照组,G:网格组,SD:睡眠剥夺组,SD+MEL睡眠剥夺加褪黑激素治疗。结论:MEL通过减轻应激、提高免疫力和维持结肠壁完整性,对psd诱导的慢性代谢功能障碍和认知功能减退具有保护作用。
{"title":"The protective effect of melatonin on chronic paradoxical sleep deprivation induced metabolic and memory deficit in rats.","authors":"Omyma G Ahmed,&nbsp;Ghada S Mahmoud,&nbsp;Selvia S Samy,&nbsp;Sally A Sayed","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Backgrounds: </strong>Impaired sleep is independent risk factor of neurodegeneration and dementia. Chronic insomnia impairs melatonin (MEL) production that is directly proportionate to its duration. The underlying mechanisms linking sleep loss to dementia and the possible therapeutic effect of melatonin have not been fully elucidated. Previous research showed great controversy concerning the effects of paradoxical sleep deprivation (PSD) on body weight, serum lipoproteins, and inflammatory cytokines.</p><p><strong>Goals: </strong>To examine the effect of chronic paradoxical sleep deprivation (PSD) with and without MEL supplementation on memory using RAWM, parameters of metabolic syndrome (MS), liver enzymes, serum cortisol, and inflammatory cytokines as well as liver, colon, and brain histopathology.</p><p><strong>Methods: </strong>Forty rats were divided into four groups ten animals each; C: control, G: grid group, SD: sleep deprivation group, and SD+MEL sleep deprivation treated with melatonin.</p><p><strong>Results: </strong>MEL supplementation reversed PSD-induced memory deficits (P<0.05), the elevation of serum cortisol (P<0.001), glucose (P<0.05), ALT (P<0.05), AST (P<0.001), TNF-alpha (P<0.001), IL-10 (P<0.01) and improved colon, liver, and brain architecture. Melatonin reduced body weight (P<0.05), total cholesterol, LDL-c, and triglycerides as well as increased HDL-c (P<0.001).</p><p><strong>Conclusion: </strong>MEL has a protective effect against chronic PSD-induced metabolic malfunction and cognitive deterioration by reducing stress, improving immunity, and maintaining colonic wall integrity.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 3","pages":"56-74"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349320/pdf/ijppp0015-0056.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9829480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Shenqi millet porridge on gastrointestinal function decline. 参芪小米粥对胃肠功能衰退的影响。
Chaojun Xi, Xin Wang, Fubo Tian

Objective: To explore the effect of Shenqi millet porridge on treating gastrointestinal function decline.

Methods: Clinical data of 72 patients with gastrointestinal function decline were retrospectively analyzed. Patients were divided into an observation group (n=36, treated with Shenqi millet porridge) and a control group (n=36, treated with Changweikang granule) according to the treatment methods. The therapeutic effect, quality of life, nutritional status, and levels of motilin and gastrin were analyzed.

Results: The total response rate of the observation group was significantly higher than that of the control group (97.22% vs. 72.22%; P<0.05). Compared with the control group, the quality of life in the observation group was increased after treatment (all P<0.05), and the total protein and body mass index in the observation group were higher than those in the control group (all P<0.05), while the levels of motilin and gastrin in the observation group were lower than those in the control group (all P<0.05).

Conclusion: For patients with gastrointestinal function decline, the therapeutic regimen Shenqi millet porridge ameliorates the nutritional status of patients, as well as the quality of life and total therapeutic efficacy, also reduces the levels of motilin and gastrin. This regimen has high safety and clinical application value.

目的:探讨参芪小米粥对胃肠功能减退的治疗作用。方法:回顾性分析72例胃肠功能减退患者的临床资料。根据治疗方法将患者分为观察组(36例,用参芪小米粥治疗)和对照组(36例,用胃胃康颗粒治疗)。分析治疗效果、生活质量、营养状况、胃动素和胃泌素水平。结果:观察组患者总有效率显著高于对照组(97.22% vs. 72.22%;结论:对于胃肠功能下降的患者,参芪小米粥治疗方案改善了患者的营养状况,改善了患者的生活质量和总治疗效果,降低了胃动素和胃泌素水平。该方案具有较高的安全性和临床应用价值。
{"title":"Effect of Shenqi millet porridge on gastrointestinal function decline.","authors":"Chaojun Xi,&nbsp;Xin Wang,&nbsp;Fubo Tian","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the effect of Shenqi millet porridge on treating gastrointestinal function decline.</p><p><strong>Methods: </strong>Clinical data of 72 patients with gastrointestinal function decline were retrospectively analyzed. Patients were divided into an observation group (n=36, treated with Shenqi millet porridge) and a control group (n=36, treated with Changweikang granule) according to the treatment methods. The therapeutic effect, quality of life, nutritional status, and levels of motilin and gastrin were analyzed.</p><p><strong>Results: </strong>The total response rate of the observation group was significantly higher than that of the control group (97.22% vs. 72.22%; P<0.05). Compared with the control group, the quality of life in the observation group was increased after treatment (all P<0.05), and the total protein and body mass index in the observation group were higher than those in the control group (all P<0.05), while the levels of motilin and gastrin in the observation group were lower than those in the control group (all P<0.05).</p><p><strong>Conclusion: </strong>For patients with gastrointestinal function decline, the therapeutic regimen Shenqi millet porridge ameliorates the nutritional status of patients, as well as the quality of life and total therapeutic efficacy, also reduces the levels of motilin and gastrin. This regimen has high safety and clinical application value.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 2","pages":"50-55"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195210/pdf/ijppp0015-0050.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9498013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized controlled trial to assess the effect of isotonic normal saline versus water post-Ryles Tube feeding for correcting hyponatremia among ICU patients at tertiary care hospital: a pilot study. 一项随机对照试验,评估三级护理医院ICU患者ryles管喂养后等渗生理盐水与水对纠正低钠血症的效果:一项初步研究。
Neetu Kataria, Hoineiting Rebecca Haokip, Vasantha C Kalyani

Objectives: To assess the effect of isotonic normal saline (NS) versus water post-Ryles Tube (RT) feeding upon hyponatremia and blood parameters in Intensive Care Units (ICU) admitted patients.

Methods: A parallel group randomized controlled trial design. The total sample size taken for this pilot trial was N = 50 as a thumb rule (n = 25 in each arm) selected by using a simple random sampling method. The sample was ICU-admitted patients with mild and moderate hyponatremia.at tertiary care hospital, Rishikesh. Intervention-20 mL Isotonic 0.9% normal saline (NS) among the experimental group vs. 20 mL water in the control group after each 9 am Ryles tube feeding respectively for three continuous days. At baseline and follow-up electrolytes, blood parameters, Glasgow Coma Scale (GCS), and blood pressures were assessed post-one hour of intervention daily for day-1, 2, 3 & 5. Data were analyzed by using descriptive & inferential statistics in the SPSS software 23.0 version.

Results: There was a significant difference found between the experimental and control groups for the post-test value of serum sodium levels, GCS, Systolic Blood Pressure, and Diastolic Blood Pressure (DBP) at day 1 of administration of normal saline intervention with p-value < 0.0001. However, it was found significant at day 5 between both groups for the above-mentioned variables.

Conclusion: The intervention of normal saline was found to be a cheaper and more effective remedy to treat hyponatremia and reduce mortality among ICU-admitted patients due to deterioration in bio-physiological parameters.

目的:评价等渗生理盐水(NS)与水(RT)对重症监护病房(ICU)住院患者低钠血症和血液参数的影响。方法:采用平行组随机对照试验设计。本次先导试验的总样本量为N = 50,为经验法则(每组N = 25),采用简单随机抽样方法选择。样本为icu收治的轻、中度低钠血症患者。在里希凯什的三级护理医院干预措施:实验组和对照组分别于每天上午9点Ryles管喂养后给予0.9%生理盐水20 mL等渗,连续3天。在第1,2,3和5天,每天干预1小时后评估基线和随访电解质、血液参数、格拉斯哥昏迷量表(GCS)和血压。数据采用SPSS软件23.0版的描述统计和推理统计进行分析。结果:实验组与对照组在生理盐水干预第1天的血钠水平、GCS、收缩压、舒张压(DBP)试验后值差异有统计学意义,p值< 0.0001。然而,在第5天,两组之间的上述变量均具有显著性。结论:生理盐水干预治疗低钠血症是一种更经济有效的治疗方法,可降低icu住院患者因生物生理参数恶化导致的死亡率。
{"title":"A randomized controlled trial to assess the effect of isotonic normal saline versus water post-Ryles Tube feeding for correcting hyponatremia among ICU patients at tertiary care hospital: a pilot study.","authors":"Neetu Kataria,&nbsp;Hoineiting Rebecca Haokip,&nbsp;Vasantha C Kalyani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the effect of isotonic normal saline (NS) versus water post-Ryles Tube (RT) feeding upon hyponatremia and blood parameters in Intensive Care Units (ICU) admitted patients.</p><p><strong>Methods: </strong>A parallel group randomized controlled trial design. The total sample size taken for this pilot trial was N = 50 as a thumb rule (n = 25 in each arm) selected by using a simple random sampling method. The sample was ICU-admitted patients with mild and moderate hyponatremia.at tertiary care hospital, Rishikesh. <i>Intervention</i>-20 mL Isotonic 0.9% normal saline (NS) among the experimental group vs. 20 mL water in the control group after each 9 am Ryles tube feeding respectively for three continuous days. At baseline and follow-up electrolytes, blood parameters, Glasgow Coma Scale (GCS), and blood pressures were assessed post-one hour of intervention daily for day-1, 2, 3 & 5. Data were analyzed by using descriptive & inferential statistics in the SPSS software 23.0 version.</p><p><strong>Results: </strong>There was a significant difference found between the experimental and control groups for the post-test value of serum sodium levels, GCS, Systolic Blood Pressure, and Diastolic Blood Pressure (DBP) at day 1 of administration of normal saline intervention with <i>p</i>-value < 0.0001. However, it was found significant at day 5 between both groups for the above-mentioned variables.</p><p><strong>Conclusion: </strong>The intervention of normal saline was found to be a cheaper and more effective remedy to treat hyponatremia and reduce mortality among ICU-admitted patients due to deterioration in bio-physiological parameters.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 2","pages":"31-40"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195212/pdf/ijppp0015-0031.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9505288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV-1 envelope protein gp120 modulation of glutamate effects on cortical neuronal synapses: implications for HIV-1-associated neuropathogenesis. 谷氨酸对皮质神经元突触影响的HIV-1包膜蛋白gp120调节:与HIV-1相关的神经发病机制的含义。
Jianuo Liu, Jinyan Xie, Debashis Dutta, Huangui Xiong

Despite the introduction of combined antiretroviral therapy (cART) HIV-1 virus persists in the brain in a latent or restricted manner and viral proteins, such as gp120, continue to play a significant disease-inciting role. Gp120 is known to interact with N-methyl-D-aspartate (NMDA) receptors (NMDARs) resulting in neuronal injury. Glutamate is the main excitatory neurotransmitter in the brain and plays an important role in cognitive function and dysregulation of excitatory synaptic transmission impairs neurocognition. It is our hypothesis that gp120 may alter synaptic function via modulating glutamate function from a physiological molecule to a pathophysiological substance. To test this hypothesis, we studied the modulatory effects of gp120 and glutamate on NMDAR-mediated spontaneous excitatory postsynaptic current (sEPSCNMDAR) and dynamic dendritic spine changes in rat cortical neuronal cultures. Our results revealed that gp120 and glutamate each, at low concentrations, had no significant effects on sEPSCNMDAR and dendritic spines, but increased sEPSCNMDAR frequency, decreased numbers of dendritic spines when tested in combination. The observed effects were blocked by either a CXCR4 blocker or an NMDAR antagonist, indicating the involvements of chemokine receptor CXCR4 and NMDARs in gp120 modulation of glutamate effects. These results may imply a potential mechanism for HIV-1-associated neuropathogenesis in the cART era.

尽管引入了联合抗逆转录病毒疗法(cART), HIV-1病毒仍以潜伏或受限的方式持续存在于大脑中,病毒蛋白,如gp120,继续发挥着重要的疾病刺激作用。已知Gp120与n -甲基- d -天冬氨酸(NMDA)受体(NMDARs)相互作用导致神经元损伤。谷氨酸是大脑中主要的兴奋性神经递质,在认知功能中起重要作用,兴奋性突触传递失调会损害神经认知。我们的假设是gp120可能通过调节谷氨酸从生理分子到病理生理物质的功能来改变突触功能。为了验证这一假设,我们研究了gp120和谷氨酸对nmdar介导的自发兴奋性突触后电流(sEPSCNMDAR)和大鼠皮层神经元培养中树突棘动态变化的调节作用。结果显示,低浓度gp120和谷氨酸对sEPSCNMDAR和树突棘均无显著影响,但联合使用时sEPSCNMDAR频率增加,树突棘数量减少。观察到的效应被CXCR4阻滞剂或NMDAR拮抗剂阻断,表明趋化因子受体CXCR4和NMDARs参与gp120调节谷氨酸的作用。这些结果可能暗示了cART时代hiv -1相关神经发病机制的潜在机制。
{"title":"HIV-1 envelope protein gp120 modulation of glutamate effects on cortical neuronal synapses: implications for HIV-1-associated neuropathogenesis.","authors":"Jianuo Liu,&nbsp;Jinyan Xie,&nbsp;Debashis Dutta,&nbsp;Huangui Xiong","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite the introduction of combined antiretroviral therapy (cART) HIV-1 virus persists in the brain in a latent or restricted manner and viral proteins, such as gp120, continue to play a significant disease-inciting role. Gp120 is known to interact with <i>N</i>-methyl-<i>D</i>-aspartate (NMDA) receptors (NMDARs) resulting in neuronal injury. Glutamate is the main excitatory neurotransmitter in the brain and plays an important role in cognitive function and dysregulation of excitatory synaptic transmission impairs neurocognition. It is our hypothesis that gp120 may alter synaptic function via modulating glutamate function from a physiological molecule to a pathophysiological substance. To test this hypothesis, we studied the modulatory effects of gp120 and glutamate on NMDAR-mediated spontaneous excitatory postsynaptic current (sEPSC<sub>NMDAR</sub>) and dynamic dendritic spine changes in rat cortical neuronal cultures. Our results revealed that gp120 and glutamate each, at low concentrations, had no significant effects on sEPSC<sub>NMDAR</sub> and dendritic spines, but increased sEPSC<sub>NMDAR</sub> frequency, decreased numbers of dendritic spines when tested in combination. The observed effects were blocked by either a CXCR4 blocker or an NMDAR antagonist, indicating the involvements of chemokine receptor CXCR4 and NMDARs in gp120 modulation of glutamate effects. These results may imply a potential mechanism for HIV-1-associated neuropathogenesis in the cART era.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 3","pages":"75-87"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349318/pdf/ijppp0015-0075.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9816685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute paracetamol toxicity-induced inflammatory and oxidative effects are relieved by Aleppo galls: a novel experimental study. 急性扑热息痛毒性诱导的炎症和氧化作用由阿勒颇胆囊缓解:一项新的实验研究。
Ahmed Alamir Mahmoud Abdallah, Rawan Bafail, Amal Yaseen Zaman, Ahmed J Aldhafiri, Ali Alalawi, Faten M Omran, Hussam H Baghdadi, Wafaa A Abdellah, Abdullah Mahfouz Alsharif, Sultan S Al Thagfan, Ibrahim M Abdel-Rahman, Samer A El-Sawy, Mehrevan M Abd Elmoniem, Salah Mohamed El Sayed, Hytham Mahmoud Abdel-Latif

Background: Paracetamol (acetaminophen) is an over-the-counter non-steroidal anti-inflammatory drug that may cause acute toxic overdosage particularly in neuropsychiatric patients. Paracetamol is also very commonly prescribed as an analgesic and antipyretic agent. Paracetamol toxicity causes decreased reduced glutathione and oxidative tissue damage. Aleppo galls is a promising natural remedy exerting antioxidant and tissue-protective effects that may combat acetaminophen-induced oxidative tissue damage.

Methodology: Biochemical and toxicological effects of a toxic dose of paracetamol (250 mg/kg) were investigated for three consecutive days versus the tissue-protective effects of Aleppo galls. Eighteen white albino mice were randomly allocated in this study and divided into three experimental groups (six mice per group): negative control (received intraperitoneal sterile water injection), paracetamol toxicity group (received intraperitoneal paracetamol injection) and the third group (received paracetamol injection at 250 mg/kg/day together with oral Aleppo galls treatment at 250 mg/kg/day for 3 consecutive days). All mice were sacrificed by the end of the study.

Results: Our data revealed that paracetamol toxicity exerted significant oxidative stress damaging effects (high serum malondialdehyde, decreased serum catalase and decreased total antioxidant capacity), and significant inflammatory effects (high serum IL-6) and significant tissue-damaging effects (high serum LDH). Aleppo galls treatment significantly protected against acetaminophen toxicity-induced oxidative stress effects (P<0.001), inflammatory effects (P<0.001) and tissue-damaging effects (P<0.001).

Conclusion: Aleppo galls are promising for future drug therapeutics and for the synthesis of natural remedies for treating paracetamol toxicity. We recommend formulating Aleppo galls extract as a pharmaceutical nutrition and to be given to those who need to take large doses of paracetamol.

背景:扑热息痛(扑热息痛)是一种非处方非甾体抗炎药,可引起急性毒性过量,特别是对神经精神病人。扑热息痛也是常用的止痛药和解热药。扑热息痛毒性导致还原性谷胱甘肽减少和氧化性组织损伤。阿勒颇胆是一种很有前途的自然疗法,具有抗氧化和保护组织的作用,可以对抗对乙酰氨基酚引起的氧化性组织损伤。方法:连续3天研究有毒剂量扑热息痛(250 mg/kg)与阿勒颇胆的组织保护作用的生化和毒理学效应。本研究随机选取白化小鼠18只,分为3个实验组(每组6只):阴性对照组(腹腔注射无菌水)、扑热息痛毒性组(腹腔注射扑热息痛)和第三组(注射扑热息痛250 mg/kg/d,同时口服阿勒波胆250 mg/kg/d,连续3天)。研究结束时,所有小鼠都被处死。结果:我们的数据显示,扑热息痛毒性具有显著的氧化应激损伤作用(高血清丙二醛,降低血清过氧化氢酶和降低总抗氧化能力),显著的炎症作用(高血清IL-6)和显著的组织损伤作用(高血清LDH)。结论:阿勒颇胆在未来的药物治疗和对乙酰氨基酚毒性的自然疗法合成中具有广阔的应用前景。我们建议将阿勒颇胆囊提取物作为一种药物营养制剂,给那些需要服用大剂量扑热息痛的人服用。
{"title":"Acute paracetamol toxicity-induced inflammatory and oxidative effects are relieved by Aleppo galls: a novel experimental study.","authors":"Ahmed Alamir Mahmoud Abdallah,&nbsp;Rawan Bafail,&nbsp;Amal Yaseen Zaman,&nbsp;Ahmed J Aldhafiri,&nbsp;Ali Alalawi,&nbsp;Faten M Omran,&nbsp;Hussam H Baghdadi,&nbsp;Wafaa A Abdellah,&nbsp;Abdullah Mahfouz Alsharif,&nbsp;Sultan S Al Thagfan,&nbsp;Ibrahim M Abdel-Rahman,&nbsp;Samer A El-Sawy,&nbsp;Mehrevan M Abd Elmoniem,&nbsp;Salah Mohamed El Sayed,&nbsp;Hytham Mahmoud Abdel-Latif","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Paracetamol (acetaminophen) is an over-the-counter non-steroidal anti-inflammatory drug that may cause acute toxic overdosage particularly in neuropsychiatric patients. Paracetamol is also very commonly prescribed as an analgesic and antipyretic agent. Paracetamol toxicity causes decreased reduced glutathione and oxidative tissue damage. Aleppo galls is a promising natural remedy exerting antioxidant and tissue-protective effects that may combat acetaminophen-induced oxidative tissue damage.</p><p><strong>Methodology: </strong>Biochemical and toxicological effects of a toxic dose of paracetamol (250 mg/kg) were investigated for three consecutive days versus the tissue-protective effects of Aleppo galls. Eighteen white albino mice were randomly allocated in this study and divided into three experimental groups (six mice per group): negative control (received intraperitoneal sterile water injection), paracetamol toxicity group (received intraperitoneal paracetamol injection) and the third group (received paracetamol injection at 250 mg/kg/day together with oral Aleppo galls treatment at 250 mg/kg/day for 3 consecutive days). All mice were sacrificed by the end of the study.</p><p><strong>Results: </strong>Our data revealed that paracetamol toxicity exerted significant oxidative stress damaging effects (high serum malondialdehyde, decreased serum catalase and decreased total antioxidant capacity), and significant inflammatory effects (high serum IL-6) and significant tissue-damaging effects (high serum LDH). Aleppo galls treatment significantly protected against acetaminophen toxicity-induced oxidative stress effects (P<0.001), inflammatory effects (P<0.001) and tissue-damaging effects (P<0.001).</p><p><strong>Conclusion: </strong>Aleppo galls are promising for future drug therapeutics and for the synthesis of natural remedies for treating paracetamol toxicity. We recommend formulating Aleppo galls extract as a pharmaceutical nutrition and to be given to those who need to take large doses of paracetamol.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018072/pdf/ijppp0015-0001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9146370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective comparison of the emergent use of fixed-dose four-factor prothrombin complex versus weight-based dosing for intracranial hemorrhage assessing medication delivery time and cost. 回顾性比较急诊使用固定剂量四因子凝血酶原复合物与体重为基础剂量颅内出血评估药物递送时间和成本。
Gordon M Riha, Michael S Englehart, Karin Z Walton, Megan E Saunders, Benjamin T Carter, Simon J Thompson

Objectives: The goal of this study was to evaluate a low fixed-dose versus weight-based dosing strategy for four-factor prothrombin complex (4F-PCC) time to administration in intracranial hemorrhage (ICH) patients.

Methods: A retrospective analysis was conducted at a single rural Tertiary referral center in patients ≥18 years old on warfarin with ICH who received 4F-PCC. Continuous variables were summarized using mean (±95% CI) and compared using two-tailed tests; p values ≤0.05 were considered statistically significant.

Results: A total of 46 ICH patients were reversed using 4F-PCC (Fixed, n = 27 and Weight, n = 19). Baseline characteristics were equivalent. Total units of 4F-PCC (mean dose units 2525.1 versus 1623.3) and dose per kg were significantly reduced in the fixed-dose group. Total time from order to delivery was significantly reduced with the fixed-dose strategy (mean time 43.0 versus 29.0 minutes). Hospital length of stay (LOS), intensive care unit LOS, and mortality were equivalent with a similar mechanism. International Normalized Ratio (INR) reversal success (≤1.5) and total INR change was comparable with no difference in adverse thromboses between groups.

Conclusions: A fixed-dosed strategy reduced time to 4F-PCC administration for warfarin reversal in ICH, as compared to a weight-based strategy; with no increase in LOS, mortality, or need for additional dosing. This also resulted in significant cost savings.

目的:本研究的目的是评估低固定剂量与基于体重的给药策略对颅内出血(ICH)患者的四因素凝血酶原复合物(4F-PCC)给药时间。方法:回顾性分析在单一农村三级转诊中心对≥18岁华法林合并脑出血患者进行4F-PCC治疗。连续变量采用均值(±95% CI)汇总,采用双尾检验进行比较;P值≤0.05认为有统计学意义。结果:共有46例脑出血患者使用4F-PCC (Fixed, n = 27, Weight, n = 19)进行逆转。基线特征相同。固定剂量组4F-PCC总单位(平均剂量单位2525.1对1623.3)和每千克剂量显著降低。使用固定剂量策略,从订购到交付的总时间显著缩短(平均时间43.0分钟对29.0分钟)。住院时间(LOS)、重症监护病房LOS和死亡率具有相似的机制。国际标准化比值(INR)逆转成功率(≤1.5)和总INR变化具有可比性,两组间不良血栓发生率无差异。结论:与基于体重的策略相比,固定剂量策略减少了脑出血患者华法林逆转的4F-PCC给药时间;没有增加LOS、死亡率或需要额外剂量。这也大大节省了成本。
{"title":"A retrospective comparison of the emergent use of fixed-dose four-factor prothrombin complex versus weight-based dosing for intracranial hemorrhage assessing medication delivery time and cost.","authors":"Gordon M Riha,&nbsp;Michael S Englehart,&nbsp;Karin Z Walton,&nbsp;Megan E Saunders,&nbsp;Benjamin T Carter,&nbsp;Simon J Thompson","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>The goal of this study was to evaluate a low fixed-dose versus weight-based dosing strategy for four-factor prothrombin complex (4F-PCC) time to administration in intracranial hemorrhage (ICH) patients.</p><p><strong>Methods: </strong>A retrospective analysis was conducted at a single rural Tertiary referral center in patients ≥18 years old on warfarin with ICH who received 4F-PCC. Continuous variables were summarized using mean (±95% CI) and compared using two-tailed tests; <i>p</i> values ≤0.05 were considered statistically significant.</p><p><strong>Results: </strong>A total of 46 ICH patients were reversed using 4F-PCC (Fixed, n = 27 and Weight, n = 19). Baseline characteristics were equivalent. Total units of 4F-PCC (mean dose units 2525.1 versus 1623.3) and dose per kg were significantly reduced in the fixed-dose group. Total time from order to delivery was significantly reduced with the fixed-dose strategy (mean time 43.0 versus 29.0 minutes). Hospital length of stay (LOS), intensive care unit LOS, and mortality were equivalent with a similar mechanism. International Normalized Ratio (INR) reversal success (≤1.5) and total INR change was comparable with no difference in adverse thromboses between groups.</p><p><strong>Conclusions: </strong>A fixed-dosed strategy reduced time to 4F-PCC administration for warfarin reversal in ICH, as compared to a weight-based strategy; with no increase in LOS, mortality, or need for additional dosing. This also resulted in significant cost savings.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 3","pages":"98-104"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349319/pdf/ijppp0015-0098.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9826916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of 15% lysine cream in treating diabetic foot ulcers: a randomized interventional study. 15%赖氨酸乳膏治疗糖尿病足溃疡的疗效:一项随机介入研究。
Shashikumara Shashikumara, Vani Jayaraman, Prathima Chikkegowda, Darshan Channapatna Lingaiah, Bhuvanesh Sukhlal Kalal

Background and objective: Lysine is an essential amino acid involved in several biochemical pathways. It has been shown to enhance blood supply and target growth factors, leading to improved wound healing. The present study aimed to evaluate the efficacy and tolerability of a 15% lysine cream in treating diabetic foot ulcers, as measured by the Bates-Jensen Wound Assessment Tool (BWAT).

Materials and method: A randomized, open-label, interventional study was conducted on 40 volunteers with diabetic ulcers. The treatment group (n=20) received well-known treatment along with lysine cream (15%) twice daily, while the control group (n=20) received standard therapy alone. Wound healing was evaluated using the BWAT. The student t-test and one-way ANOVA were used to compare the clinical assessment parameters to the baseline.

Results: Both groups showed a significant decrease in ulcer size, depth, edges, undermining, necrotic tissue type, necrotic tissue amount, exudate type, and exudate amount over six weeks, with no significant difference between the groups after the first week. The lysine-treated group showed a significant improvement in wound healing compared to the control group (P<0.05).

Conclusion: The present study demonstrates that a 15% lysine cream can significantly improve wound healing in diabetic foot ulcer patients, as measured by the BWAT, compared to standard treatment alone. Further research is needed to confirm these findings and to explore the underlying mechanisms of lysine's therapeutic effects.

背景与目的:赖氨酸是参与多种生物化学途径的必需氨基酸。它已被证明可以增强血液供应和目标生长因子,从而改善伤口愈合。本研究旨在通过Bates-Jensen伤口评估工具(BWAT)评估15%赖氨酸乳膏治疗糖尿病足溃疡的疗效和耐受性。材料与方法:对40例糖尿病溃疡患者进行随机、开放标签、介入性研究。治疗组(n=20)采用知名疗法联合赖氨酸乳膏(15%)治疗,每日2次,对照组(n=20)采用标准疗法。采用BWAT评价伤口愈合情况。采用学生t检验和单因素方差分析比较临床评估参数与基线。结果:两组在6周内溃疡的大小、深度、边缘、破坏程度、坏死组织类型、坏死组织数量、渗出物类型、渗出物数量均显著减少,第一周后两组间差异无统计学意义。与对照组相比,赖氨酸治疗组伤口愈合明显改善(p结论:本研究表明,与单独标准治疗相比,15%赖氨酸乳膏可以显著改善糖尿病足溃疡患者的伤口愈合,通过BWAT测量。需要进一步的研究来证实这些发现,并探索赖氨酸治疗作用的潜在机制。
{"title":"Efficacy of 15% lysine cream in treating diabetic foot ulcers: a randomized interventional study.","authors":"Shashikumara Shashikumara,&nbsp;Vani Jayaraman,&nbsp;Prathima Chikkegowda,&nbsp;Darshan Channapatna Lingaiah,&nbsp;Bhuvanesh Sukhlal Kalal","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and objective: </strong>Lysine is an essential amino acid involved in several biochemical pathways. It has been shown to enhance blood supply and target growth factors, leading to improved wound healing. The present study aimed to evaluate the efficacy and tolerability of a 15% lysine cream in treating diabetic foot ulcers, as measured by the Bates-Jensen Wound Assessment Tool (BWAT).</p><p><strong>Materials and method: </strong>A randomized, open-label, interventional study was conducted on 40 volunteers with diabetic ulcers. The treatment group (n=20) received well-known treatment along with lysine cream (15%) twice daily, while the control group (n=20) received standard therapy alone. Wound healing was evaluated using the BWAT. The student t-test and one-way ANOVA were used to compare the clinical assessment parameters to the baseline.</p><p><strong>Results: </strong>Both groups showed a significant decrease in ulcer size, depth, edges, undermining, necrotic tissue type, necrotic tissue amount, exudate type, and exudate amount over six weeks, with no significant difference between the groups after the first week. The lysine-treated group showed a significant improvement in wound healing compared to the control group (P<0.05).</p><p><strong>Conclusion: </strong>The present study demonstrates that a 15% lysine cream can significantly improve wound healing in diabetic foot ulcer patients, as measured by the BWAT, compared to standard treatment alone. Further research is needed to confirm these findings and to explore the underlying mechanisms of lysine's therapeutic effects.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 3","pages":"88-97"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349317/pdf/ijppp0015-0088.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9826914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NAD+ administration profoundly decreases UVC-induced skin damage by attenuating oxidative stress, inflammation, DNA damage and apoptosis. NAD+通过减轻氧化应激、炎症、DNA损伤和细胞凋亡,显著降低uvc诱导的皮肤损伤。
Mengmeng Li, Mingchao Zhang, Yin Zhang, Yu Liang, Weihai Ying

Ultraviolet (UV) radiation is a major cause of multiple major skin diseases including skin cancer. It is crucial to discover new agents that can produce profound protective effects on UV-produced skin damage. Using a mouse model, in this study we determined the effects of NAD+ on UVC-induced skin damage and investigated the mechanisms underlying the effects, obtaining the following discoveries: First, UVC-induced skin's green autofluorescence (AF) was highly correlated with the extent of UVC-indued skin's damage; second, NAD+ administration profoundly decreased UVC-induced skin damage; third, NAD+ administration significantly attenuated UVC-induced decreases in the levels of mitochondrial superoxide dismutase and catalase; fourth, NAD+ administration significantly attenuated UVC-induced increase in the level of cyclooxygenase (COX) 2 - a marker of inflammation; fifth, NAD+ administration profoundly attenuated UVC-induced increase in double-strand DNA (dsDNA) damage; and sixth, NAD+ administration profoundly attenuated UVC-induced decreases in the ratios of Bcl-2/Bax - an index of apoptosis. Collectively, our study has found that NAD+ administration can profoundly decrease UVC-induced skin damage by attenuating oxidative stress, inflammation, DNA damage, and apoptosis, suggesting great potential of NAD+ as a protective agent for UVC-induced skin damage. Moreover, our study has further indicated that the skin's green AF is a biomarker for predicting UVC-induced skin damage.

紫外线辐射是导致包括皮肤癌在内的多种皮肤疾病的主要原因。发现能够对紫外线造成的皮肤损伤产生深远保护作用的新药剂是至关重要的。本研究通过小鼠模型,确定了NAD+对uvc诱导的皮肤损伤的影响,并探讨了其作用机制,得到以下发现:首先,uvc诱导的皮肤绿色自身荧光(AF)与uvc诱导的皮肤损伤程度高度相关;第二,NAD+可显著降低uvc引起的皮肤损伤;第三,NAD+显著减弱了uvc诱导的线粒体超氧化物歧化酶和过氧化氢酶水平的下降;第四,NAD+显著减弱了uvc诱导的环氧化酶(COX) 2水平的升高,COX 2是炎症的标志;第五,NAD+能显著减弱uvc诱导的双链DNA (dsDNA)损伤的增加;第六,NAD+能显著减弱uvc诱导的Bcl-2/Bax比值的下降,Bcl-2/Bax是细胞凋亡的指标。总的来说,我们的研究发现NAD+可以通过减轻氧化应激、炎症、DNA损伤和细胞凋亡来显著减少uvc诱导的皮肤损伤,这表明NAD+作为uvc诱导的皮肤损伤的保护剂具有很大的潜力。此外,我们的研究进一步表明,皮肤的绿色AF是预测uvc诱导的皮肤损伤的生物标志物。
{"title":"NAD<sup>+</sup> administration profoundly decreases UVC-induced skin damage by attenuating oxidative stress, inflammation, DNA damage and apoptosis.","authors":"Mengmeng Li,&nbsp;Mingchao Zhang,&nbsp;Yin Zhang,&nbsp;Yu Liang,&nbsp;Weihai Ying","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Ultraviolet (UV) radiation is a major cause of multiple major skin diseases including skin cancer. It is crucial to discover new agents that can produce profound protective effects on UV-produced skin damage. Using a mouse model, in this study we determined the effects of NAD<sup>+</sup> on UVC-induced skin damage and investigated the mechanisms underlying the effects, obtaining the following discoveries: First, UVC-induced skin's green autofluorescence (AF) was highly correlated with the extent of UVC-indued skin's damage; second, NAD<sup>+</sup> administration profoundly decreased UVC-induced skin damage; third, NAD<sup>+</sup> administration significantly attenuated UVC-induced decreases in the levels of mitochondrial superoxide dismutase and catalase; fourth, NAD<sup>+</sup> administration significantly attenuated UVC-induced increase in the level of cyclooxygenase (COX) 2 - a marker of inflammation; fifth, NAD<sup>+</sup> administration profoundly attenuated UVC-induced increase in double-strand DNA (dsDNA) damage; and sixth, NAD<sup>+</sup> administration profoundly attenuated UVC-induced decreases in the ratios of Bcl-2/Bax - an index of apoptosis. Collectively, our study has found that NAD<sup>+</sup> administration can profoundly decrease UVC-induced skin damage by attenuating oxidative stress, inflammation, DNA damage, and apoptosis, suggesting great potential of NAD<sup>+</sup> as a protective agent for UVC-induced skin damage. Moreover, our study has further indicated that the skin's green AF is a biomarker for predicting UVC-induced skin damage.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 2","pages":"41-49"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195211/pdf/ijppp0015-0041.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9498010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of yoga on Ewing's battery autonomic function test: cross-sectional study. 瑜伽对Ewing电池自主功能测试的有效性:横断面研究。
Tasneem Amadawala, Charushila Rukadikar, Dileep Deshpande, Atul Rukadikar, Ravi Bhatt

Introduction: The cardiovascular autonomic functions can be tested by a Battery of five tests developed by Ewing and Clark in 1981 in Edinburgh. Yogic practices are immensely useful for physical, mental and spiritual development required for better autonomic function.

Aim and objectives: To assess the ANS (Autonomic function system) function with help of Ewing's Battery tests in yoga participants and healthy participants not practicing yoga.

Materials and methods: A cross-sectional study was conducted on 270 participants which were divided into two groups viz: 135 in healthy control (Group I) and 135 in yoga group (Group II). Subjects with informed consent between 40-50 years, were included in control (Group I) and those practicing yoga for past minimum 3 months were included in Group II. Anthropometric measurements were done and parasympathetic tests like Heart rate (HR) response to standing from the supine posture, to Valsalva maneuvers and to slow deep breathing were done. Also, sympathetic tests, Blood Pressure (BP) response to cold in cold pressor test (CPT), to sustained handgrip test and to standing from lying posture were carried out.

Results: P value was found to be statically significant among yoga group as compared with healthy control group in all the sympathetic and parasympathetic tests except in CPT. As per the Ewing's criteria, normal, early, diseased and severe CAN (Cardiac autonomic neuropathy) in healthy controls findings were 11.11%, 58.51%, 37.03%, 17.77% and in yoga participants findings were 37.7%, 34.8%, 6.66% and 8.88% respectively. According to Bellavere's classification, maximum diseased CAN were found in healthy control as compared to yoga group. As per AIIMS (All India Institute of Medical Sciences) criteria, parasympathetic neuropathy was observed in 11.85% of the healthy controls and in 6.66% of the yoga group, and that maximum sympathetic neuropathy was observed in 11.11% of the healthy patients and only 3.7% of the yoga group.

Conclusion: More emphasis should be given on implementation of yoga from early ages at the institutional levels, hospital levels. Yoga practices will suffice and lead to improvement of unhealthy ANS condition. Overall, Yoga showed better ANS function than healthy control group.

导言:心血管自主功能可以通过Ewing和Clark于1981年在爱丁堡开发的五组测试来测试。瑜伽练习对更好的自主神经功能所需的身体、心理和精神发展非常有用。目的:利用尤因电池测试对瑜伽练习者和未练习瑜伽的健康人的自主神经系统功能进行评估。材料与方法:对270名参与者进行横断面研究,分为两组:健康对照组135人(第一组)和瑜伽组135人(第二组)。知情同意年龄在40-50岁之间的受试者为对照组(第一组),练习瑜伽至少3个月的受试者为第二组。进行了人体测量,并进行了副交感神经系统测试,如从仰卧姿势站立、瓦尔萨尔瓦动作和缓慢深呼吸的心率(HR)反应。同时进行交感神经测试、冷压试验(CPT)中血压(BP)对寒冷的反应、持续握力测试和站立姿势。结果:除CPT外,瑜伽组的交感神经和副交感神经各项指标与健康对照组比较,P值均有统计学意义。按照Ewing’s标准,正常、早期、病变和重度CAN(心脏自主神经病变)在健康对照组的检出率分别为11.11%、58.51%、37.03%、17.77%,瑜伽组的检出率分别为37.7%、34.8%、6.66%和8.88%。根据Bellavere的分类,与瑜伽组相比,健康对照组中病变的CAN最多。根据AIIMS(全印度医学科学研究所)的标准,11.85%的健康对照组和6.66%的瑜伽组观察到副交感神经病变,11.11%的健康患者和3.7%的瑜伽组观察到最大的交感神经病变。结论:应从机构层面、医院层面重视瑜伽的早期实施。瑜伽练习足以改善不健康的ANS状况。总体而言,瑜伽组的ANS功能优于健康对照组。
{"title":"Effectiveness of yoga on Ewing's battery autonomic function test: cross-sectional study.","authors":"Tasneem Amadawala,&nbsp;Charushila Rukadikar,&nbsp;Dileep Deshpande,&nbsp;Atul Rukadikar,&nbsp;Ravi Bhatt","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The cardiovascular autonomic functions can be tested by a Battery of five tests developed by Ewing and Clark in 1981 in Edinburgh. Yogic practices are immensely useful for physical, mental and spiritual development required for better autonomic function.</p><p><strong>Aim and objectives: </strong>To assess the ANS (Autonomic function system) function with help of Ewing's Battery tests in yoga participants and healthy participants not practicing yoga.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted on 270 participants which were divided into two groups viz: 135 in healthy control (Group I) and 135 in yoga group (Group II). Subjects with informed consent between 40-50 years, were included in control (Group I) and those practicing yoga for past minimum 3 months were included in Group II. Anthropometric measurements were done and parasympathetic tests like Heart rate (HR) response to standing from the supine posture, to Valsalva maneuvers and to slow deep breathing were done. Also, sympathetic tests, Blood Pressure (BP) response to cold in cold pressor test (CPT), to sustained handgrip test and to standing from lying posture were carried out.</p><p><strong>Results: </strong><i>P</i> value was found to be statically significant among yoga group as compared with healthy control group in all the sympathetic and parasympathetic tests except in CPT. As per the Ewing's criteria, normal, early, diseased and severe CAN (Cardiac autonomic neuropathy) in healthy controls findings were 11.11%, 58.51%, 37.03%, 17.77% and in yoga participants findings were 37.7%, 34.8%, 6.66% and 8.88% respectively. According to Bellavere's classification, maximum diseased CAN were found in healthy control as compared to yoga group. As per AIIMS (All India Institute of Medical Sciences) criteria, parasympathetic neuropathy was observed in 11.85% of the healthy controls and in 6.66% of the yoga group, and that maximum sympathetic neuropathy was observed in 11.11% of the healthy patients and only 3.7% of the yoga group.</p><p><strong>Conclusion: </strong>More emphasis should be given on implementation of yoga from early ages at the institutional levels, hospital levels. Yoga practices will suffice and lead to improvement of unhealthy ANS condition. Overall, Yoga showed better ANS function than healthy control group.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 2","pages":"21-30"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195213/pdf/ijppp0015-0021.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9498008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of PD-L1 antigen expression using immunohistochemistry technique in medullary thyroid carcinoma samples. 应用免疫组织化学技术评价甲状腺髓样癌标本中PD-L1抗原的表达。
Behnaz Karkheiran, Behnaz Jahanbin, Golnoosh Shahverdi, Vahid Soleimani

Background: Markers related to the mechanism of tumoral cell escape from the immune system have received more attention. The PD-L1 molecule encoded by the "CD274" gene binds to T lymphocytes and can inhibit these cells. Therefore, increasing the expression of this marker on inflammatory or tumor cells can indicate tumor progression invasiveness and long-term consequences. The present study aimed to determine the expression of the PD-L1 marker in thyroid medullary tumors and to evaluate its role in predicting long-term outcomes after cancer.

Methods: This retrospective longitudinal study was performed on pathology samples of patients with medullary thyroid carcinoma referred to the Cancer Institute of Imam Khomeini Hospital from 2015 to 2020. Slides related to medullary thyroid tumors were examined. A tissue microarray was used to evaluate the immunohistochemistry of PD-L1. Patients were followed up to assess the occurrence of recurrence. Out of 207 patients evaluated in the present study, histopathological information of 144 patients was available.

Results: The expression rate of PD-L1 in our community was 14.6% in lymphocyte cells, 35.4% in tumor cells, and 12.5% in both cells. The presence of metastasis at the time of diagnosis was reported in 35 cases (72.9%), and the occurrence of tumor recurrence was reported in 38 cases (79.2%). There was no relationship between the expression of this marker and the sex and age of patients. In addition, PD-L1 expression was unrelated to the two main characteristics of this cancer, namely tumor size and its focality. The presentation of tumor PD (L1) (but not lymphocytic) was a prognostic marker for synchronous metastasis at cancer diagnosis but could not predict tumor recurrence.

Conclusion: PD-L1 tumor marker expression is predictable in 14.6% of lymphocyte cells, 35.4% of tumor cells, and 12.5% in the selected Iranian population with medullary thyroid cancer. The expression of this marker is not related to the morphological characteristics of the tumor, such as tumor size or focality.

背景:与肿瘤细胞逃离免疫系统机制相关的标志物越来越受到人们的关注。由“CD274”基因编码的PD-L1分子与T淋巴细胞结合并能抑制这些细胞。因此,在炎症或肿瘤细胞中增加该标记物的表达可以提示肿瘤的进展、侵袭性和长期后果。本研究旨在确定PD-L1标志物在甲状腺髓样肿瘤中的表达,并评估其在预测癌症后长期预后中的作用。方法:对2015年至2020年伊玛目霍梅尼医院癌症研究所转诊的甲状腺髓样癌患者的病理样本进行回顾性纵向研究。检查与甲状腺髓样肿瘤有关的载玻片。采用组织微阵列技术评价PD-L1的免疫组织化学。对患者进行随访,评估复发情况。在本研究评估的207例患者中,有144例患者的组织病理学信息可用。结果:我们社区PD-L1在淋巴细胞中的表达率为14.6%,在肿瘤细胞中的表达率为35.4%,在两种细胞中的表达率分别为12.5%。诊断时有转移的35例(72.9%),肿瘤复发38例(79.2%)。该标记物的表达与患者的性别和年龄没有关系。此外,PD-L1的表达与该癌症的两个主要特征,即肿瘤大小和病灶性无关。肿瘤PD (L1)的出现(但不是淋巴细胞)是癌症诊断时同步转移的预后标志物,但不能预测肿瘤复发。结论:PD-L1肿瘤标志物在14.6%的淋巴细胞、35.4%的肿瘤细胞和12.5%的伊朗甲状腺髓样癌患者中可预测表达。该标志物的表达与肿瘤的形态学特征无关,如肿瘤大小或病灶。
{"title":"Evaluation of PD-L1 antigen expression using immunohistochemistry technique in medullary thyroid carcinoma samples.","authors":"Behnaz Karkheiran,&nbsp;Behnaz Jahanbin,&nbsp;Golnoosh Shahverdi,&nbsp;Vahid Soleimani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Markers related to the mechanism of tumoral cell escape from the immune system have received more attention. The PD-L1 molecule encoded by the \"CD274\" gene binds to T lymphocytes and can inhibit these cells. Therefore, increasing the expression of this marker on inflammatory or tumor cells can indicate tumor progression invasiveness and long-term consequences. The present study aimed to determine the expression of the PD-L1 marker in thyroid medullary tumors and to evaluate its role in predicting long-term outcomes after cancer.</p><p><strong>Methods: </strong>This retrospective longitudinal study was performed on pathology samples of patients with medullary thyroid carcinoma referred to the Cancer Institute of Imam Khomeini Hospital from 2015 to 2020. Slides related to medullary thyroid tumors were examined. A tissue microarray was used to evaluate the immunohistochemistry of PD-L1. Patients were followed up to assess the occurrence of recurrence. Out of 207 patients evaluated in the present study, histopathological information of 144 patients was available.</p><p><strong>Results: </strong>The expression rate of PD-L1 in our community was 14.6% in lymphocyte cells, 35.4% in tumor cells, and 12.5% in both cells. The presence of metastasis at the time of diagnosis was reported in 35 cases (72.9%), and the occurrence of tumor recurrence was reported in 38 cases (79.2%). There was no relationship between the expression of this marker and the sex and age of patients. In addition, PD-L1 expression was unrelated to the two main characteristics of this cancer, namely tumor size and its focality. The presentation of tumor PD (L1) (but not lymphocytic) was a prognostic marker for synchronous metastasis at cancer diagnosis but could not predict tumor recurrence.</p><p><strong>Conclusion: </strong>PD-L1 tumor marker expression is predictable in 14.6% of lymphocyte cells, 35.4% of tumor cells, and 12.5% in the selected Iranian population with medullary thyroid cancer. The expression of this marker is not related to the morphological characteristics of the tumor, such as tumor size or focality.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"15 1","pages":"12-20"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018071/pdf/ijppp0015-0012.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9146371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of physiology, pathophysiology and pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1